<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Astellas : IR News</title>
        <link>http://www.astellas.com/en/ir/</link>
        <description></description>
        <language>en</language>
        <copyright>Copyright 2010</copyright>
        <lastBuildDate>Mon, 15 Feb 2010 14:43:52 +0900</lastBuildDate>
        <generator>http://www.sixapart.com/movabletype/</generator>
        <docs>http://www.rssboard.org/rss-specification</docs>
        
        <item>
            <title>Posted Presentation Slides for Conference Hosted by Citi.</title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Mon, 15 Feb 2010 14:43:52 +0900</pubDate>
        </item>
        
        <item>
            <title>Updated &quot;Message from CEO&quot; section. </title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Wed, 10 Feb 2010 11:51:32 +0900</pubDate>
        </item>
        
        <item>
            <title>Posted Financial Results for 3Q/FY2009</title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Tue, 02 Feb 2010 15:00:01 +0900</pubDate>
        </item>
        
        <item>
            <title>Updated &quot;IR Calendar&quot; Section</title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Tue, 02 Feb 2010 15:00:00 +0900</pubDate>
        </item>
        
        <item>
            <title>Theravance Inc. announced that it received a letter indicating that Theravance&apos;s response to the Complete Response letter for the injectable antibiotic telavancin for the treatment of nosocomial pneumonia is incomplete.</title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Fri, 29 Jan 2010 14:30:19 +0900</pubDate>
        </item>
        
        <item>
            <title>Updated &quot;Message from CEO&quot; section.</title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Mon, 18 Jan 2010 18:23:55 +0900</pubDate>
        </item>
        
        <item>
            <title>Posted Presentation Slides for Mizuho Investment Conference</title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Wed, 13 Jan 2010 17:33:41 +0900</pubDate>
        </item>
        
        <item>
            <title>Updated &quot;Stock Information&quot; Section </title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Thu, 07 Jan 2010 15:04:48 +0900</pubDate>
        </item>
        
        <item>
            <title>Updated &quot;Shareholder Return&quot; sections </title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Tue, 15 Dec 2009 14:12:21 +0900</pubDate>
        </item>
        
        <item>
            <title>Theravance Inc. announced that EMEA has completed the validation phase for the telavancin MAA for the treatment of nosocomial pneumonia and complicated skin and soft tissue infections. </title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Tue, 01 Dec 2009 13:18:48 +0900</pubDate>
        </item>
        
        <item>
            <title>Theravance Inc. announced that it received complete response letter from the FDA for the injectable antibiotic telavancin for the treatment of nosocominal pneumonia. </title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Mon, 30 Nov 2009 19:21:13 +0900</pubDate>
        </item>
        
        <item>
            <title>Updated &quot;Financial Highlights&quot; Section </title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Tue, 10 Nov 2009 11:08:41 +0900</pubDate>
        </item>
        
        <item>
            <title>Posted Presentation Slides for Information Meeting for 2Q/ FY2009 Results </title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Fri, 06 Nov 2009 13:00:00 +0900</pubDate>
        </item>
        
        <item>
            <title>Updated &quot;Shareholder Return&quot; Section </title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Thu, 05 Nov 2009 17:13:36 +0900</pubDate>
        </item>
        
        <item>
            <title>Updated &quot;Current Share Status&quot; Section</title>
            <description></description>
            <link>http://www.astellas.com/en/ir/</link>
            <guid>http://www.astellas.com/en/ir/</guid>
            
            
            <pubDate>Thu, 05 Nov 2009 17:12:01 +0900</pubDate>
        </item>
        
    </channel>
</rss>
